Eurogentec enters in the Therapeutic Oligonucleotides Manufacturing Field

Products & Services

Combining over 30 years of expertise in oligonucleotide synthesis to 20 years of biopharmaceutical GMP manufacturing, we now offer GMP therapeutic oligonucleotides manufacturing for early clinical phases.

GMP certification by the Belgium Authorities for the manufacturing and quality control of therapeutic oligonucleotides according to ICH Q7 is planned for Q1 2019.

 

 

Attached Files

Trending Now

The hidden impact of residual DNA on microbial testing and how to avoid it

Previous post

COVID-19: Build your tactics to fight de pandemic

Next post

Recommended for you

The hidden impact of residual DNA on microb..

Products & Services

This article explores the hidden risks of residual bacterial DNA contamination in qPCR reagents and...
Continue Reading
22-25 March 2026

VAAM 2026

Berlin, DE

Let's meet at "VAAM 2026"

@ Berlin, DE
📅March 22-25, 2026
📍Berlin (DE) - Booth #13...
Continue Reading
11-15 May 2026

ASGCT 2026

Boston, MA, USA

Meet our team at "ASGCT 2026"

@ Boston, MA, USA
📅May 11-15, 2026
📍Boston, MA (USA) - Booth #834...
Continue Reading